Cardiovascular disease testing on the Dimension Vista® system: Biomarkers of acute coronary syndromes

Clinical Biochemistry

Volumn 42, Issue 13-14, 2009, Pages 1444-1451

  Kelley, Walter E ^a   Lockwood, Christina M ^b   Cervelli, Denise R ^c   Sterner, Jamie ^c   Scott, Mitchell G ^b   Duh, Show Hong ^a   Christenson, Robert H ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Siemens Healthcare Diagnostics   (United States)

Author keywords

Acute coronary syndrome; Biomarkers; C reactive protein; Cardiac Troponin I; Cardiovascular diseases; Creatine Kinase; MB isoenzyme; Myoglobin; NTproBNP

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATINE KINASE MB; TROPONIN I;

ACCURACY; ACUTE CORONARY SYNDROME; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REPRODUCIBILITY;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CREATINE KINASE, MB FORM; HUMANS; IMMUNOASSAY; MYOGLOBIN; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 69249213462     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2009.05.020     Document Type: Article

References (16)

1. Rosamond W., Flegal K., Furie K., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
2. Morrow D.A., Cannon C.P., Jesse R.L., et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Circulation 115 (2007) e356-e375
3. Christenson R.H. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for utilization of biochemical markers in acute coronary syndromes and heart failure. Clin. Chem. 53 4 (2007) 545-546
4. Alpert J.S., Thygesen K., Antman E., and Bassand J.P. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36 3 (2000) 959-969
5. Apple F.S., Jesse R.L., Newby L.K., et al. National Academy of Clinical Biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin. Chem. 53 4 (2007) 547-551
6. Tang W.H., Francis G.S., Morrow D.A., et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Circulation. 116 (2007) e99-e109
7. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
8. Panteghini M., and Pagani F. AACC creatine kinase MB (CK-MB) standardization material used as manufacturer's working calibrator is unable to harmonize CK-MB results between two commercial immunoassays. Clin. Chem. 50 9 (2004) 1711-1712
9. Panteghini M., Pagani F., Yeo K.J., Apple F.S., et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin. Chem. 50 2 (2004) 327-332
10. Panteghini M., Apple F.S., Christenson R.H., Dati F., Mair J., and Wu A.H. Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Clin. Chem. Lab. Med. 37 (1999) 687-693
11. Di Serio F., Ruggieri V., Varraso L., De Sario R., Mastrorilli A., and Pansini N. Analytical evaluation of the Dade Behring Dimension RxL automated N-Terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010. Clin. Chem. Lab. Med. 43 11 (2005) 1263-1273
12. Lolekha P.H., Chittamma A., Roberts W.L., Sritara P., et al. Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clin. Biochem. 38 (2005) 31-35
13. NCCLS. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline. NCCLS document EP17-A [ISBN 1-56238-551-8]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2004.
14. Panteghini M. Clin. Chim. Acta. 402 (2009) 88-93
15. Zaninotto M., Pagani F., Altinier S., Amboni P., et al. multicenter evaluation of five assays for myoglobin determination. Clin. Chem. 46 10 (2000) 1631-1637
16. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public heath practice: a statement for healthcare professionals from the Centers of Disease Control and Prevention and the American Heart Association. Circulation. 107 (2003) 499-511